Yael Sofer

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Differential Endocrine and Metabolic Effects of Testosterone Suppressive Agents in Transgender Women

Yael Sofer, Iris Yaish, Marianna Yaron et al. · Endocrine Practice · 2020 · 54 citations

Urology, Endocrine Mechanism, Differential Endocrine +9

Why fertility preservation rates of transgender men are much lower than those of transgender women

Sharon Alpern, Iris Yaish, Gal Wagner-Kolasko et al. · Reproductive BioMedicine Online · 2022 · 30 citations

Infertility, Andrology, Gender Identity +12

Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment

Iris Yaish, Karen Tordjman, Hadar Amir et al. · Human Reproduction · 2021 · 29 citations

Gender Determines Serum Free Cortisol: Higher Levels in Men

Yael Sofer, Esther Osher, Rona Limor et al. · Endocrine Practice · 2016 · 24 citations

Gender Identity, Stress Hormone, Higher Levels +2